Debiopharm Investment S.A.

the Group's


Creating value

Our mission is to strenghten and diversify the assets of the Group to support its sustainable growth and financial autonomy.
To seek long term value creation, we manage a global balanced portfolio, commitments in private equity funds, direct minority shareholding in both non listed or listed companies, and a real estate portfolio.

Latest news
February 7, 2018

Le groupe autrichien ams acquiert KeyLemon

Read more
June 22, 2017

Sonnedix acquires Aloe Energy with 67MW solar Portfolio in France

Read more
See all news

Business model: Diversification

Financial Department

Our Financial Department is focused on:

  • Cash management
  • Currency hedging
  • Global balanced portfolio management
  • Risk management

Real Estate Department

Our Real Estate Department, Next Immobilier SA is focused on :

  • Residential and commercial real estate portfolio management –
  • Buying and developping new estates in harmony with our values
  • Giving advice & expertise to debiopharm group companies for the management of their offices and industrial real estates

Private Equity Department

Our Private Equity department is focused on investment diversification through a direct shareholding in small and mid-cap and commitments in funds. Discover its portfolio here.

Investment philosophy


Chief Executive Officer, Debiopharm International S.A.

Discover the members who guide and bring long-term vision to the company

Contact us

Got a question or a comment? Get in touch

Contact us